Viktor H Koelzer Selected Research

Fluorouracil (Carac)

1/2017

Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Viktor H Koelzer Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 06/2009
15	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2014
5	Melanoma (Melanoma, Malignant) 09/2018 - 01/2010
3	Lymphatic Metastasis 01/2018 - 07/2014
3	Neoplasm Metastasis (Metastasis) 08/2015 - 07/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2021
2	Tertiary Lymphoid Structures 01/2022 - 01/2018
2	Rectal Neoplasms (Rectal Cancer) 12/2021 - 01/2016
2	Microsatellite Instability 01/2021 - 01/2016
2	Pneumonia (Pneumonitis) 01/2018 - 01/2016
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2014
2	Disease Progression 01/2016 - 07/2014
2	Inflammation (Inflammations) 01/2016 - 01/2016
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	COVID-19 10/2020
1	Lung Diseases (Lung Disease) 10/2020
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2020
1	Ataxia (Dyssynergia) 01/2018
1	Grover's disease 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2016
1	Drug Eruptions (Drug Eruption) 01/2016
1	Polyps 01/2016
1	Pruritus (Itching) 01/2016
1	Skin Diseases (Skin Disease) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 08/2015
1	Colonic Neoplasms (Colon Cancer) 03/2015
1	Adenoma (Adenomas) 07/2014
1	Carcinoma (Carcinomatosis) 07/2014
1	Malignant Fibrous Histiocytoma 07/2014

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2013
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2014
5	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
4	LigandsIBA 01/2020 - 01/2014
4	Keratins (Keratin)IBA 07/2017 - 05/2015
4	Indicators and Reagents (Reagents)IBA 01/2016 - 01/2014
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2010
3	Biological ProductsIBA 01/2022 - 01/2021
3	CytokinesIBA 01/2018 - 07/2014
3	IpilimumabIBA 01/2018 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2018
2	Complement System Proteins (Complement)IBA 01/2022 - 05/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2016
2	Uncoupling Protein 2IBA 04/2019 - 01/2019
2	Programmed Cell Death 1 ReceptorIBA 01/2018 - 01/2016
2	Calcibiotic Root Canal SealerIBA 01/2016 - 03/2015
1	Phosphotransferases (Kinase)IBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2022
1	ChemokinesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	PlatinumIBA 01/2021
1	CateninsIBA 01/2020
1	B7-H1 AntigenIBA 09/2018
1	AntigensIBA 01/2018
1	AntibodiesIBA 01/2018
1	InterferonsIBA 01/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	DNA Polymerase IIIBA 11/2016
1	Interleukin-33IBA 01/2016
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Capecitabine (Xeloda)FDA Link 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	NivolumabIBA 01/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	InterleukinsIBA 01/2016
1	Chemokine CCL22IBA 11/2015
1	Interferon Type IIBA 11/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2015
1	tapasinIBA 08/2015
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 08/2015
1	I-antigenIBA 08/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2015
1	Hematoxylin (Haematoxylon)IBA 05/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2015
1	antineoplaston A10 (A 10)IBA 05/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2015
1	Cadherins (E-Cadherin)IBA 01/2015
1	Interleukin-23 (Interleukin 23)IBA 07/2014
1	Interleukin-23 Subunit p19IBA 07/2014
1	tocilizumab (atlizumab)FDA Link 07/2014
1	CDX2 Transcription FactorIBA 05/2014
1	ParaffinIBA 01/2014
1	Conditioned Culture MediaIBA 01/2014

Therapy/Procedure

8	Therapeutics 01/2019 - 11/2011
5	Immunotherapy 01/2022 - 06/2009
2	Lasers (Laser) 01/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2017
1	Radiotherapy 12/2021
1	Precision Medicine 01/2021
1	Neoadjuvant Therapy 01/2016